Predictive Oncology (POAI)

• Market cap: $4.6M
• 1 day: -3.82%
• 5 days: -13.80%
• 1 month: 5.67%
• 3 months: -15.52%
• 6 months: -38.97%
• Year to date: -80.46%
• 1 year: -76.30%
• 5 years: -98.79%
• 10 years: -99.71%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Employees: 35

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

4.01% less ownership

Funds ownership: 7.04% [Q2] → 3.03% (-4.01%) [Q3]

6% less funds holding

Funds holding: 18 [Q2] → 17 (-1) [Q3]

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

48% less capital invested

Capital invested by funds: $300K [Q2] → $157K (-$143K) [Q3]